AzTrials
AzTrials

Patient EngagementNCT06081660

Advance Care Planning for Older Latinos With Chronic Illness

A study testing ACP-I Plan in people with Patient Engagement and End of Life, run by San Diego State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to test the feasibility of a randomized controlled trial to learn about implementation of an intervention model, Advance Care Planning I Plan (ACP-I Plan), among older Latinos with chronic illnesses in community settings. Read more about this study

Who is it for?
Ages 50 years and olderHealthy volunteers can take part
Conditions the study is for
Patient Engagement, End of Life, Chronic Disease
What is being tested?
ACP-I Plan
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
14 Sep 2022to 16 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 50 years old or older
  • Latino/Latina or Hispanic?
  • Have 1 or more chronic health conditions

Who cannot join

  • Schizophrenia
  • Schizoaffective Disorder
  • Dementia
  • Alzheimer's disease

Trial locations and contacts

1 site in 1 country.

United States1 site
  • San Diego State University

    San Diego, California, 92182

Other trials in United States

About this study

Official title: Advance Care Planning for Older Latinos With Chronic Illness: A Feasibility Study

The goal of this study is to test the feasibility of a randomized controlled trial to learn about implementation of an intervention model, Advance Care Planning I Plan (ACP-I Plan), among older Latinos with chronic illnesses in community settings.

Read the detailed description

The goal of this study is to test the feasibility of a randomized controlled trial to learn about implementation of an intervention model, Advance Care Planning I Plan (ACP-I Plan), among older Latinos with chronic illnesses in community settings.

The questions of this study seek to explore implementation of the intervention model:

  1. To evaluate feasibility, acceptability, and preliminary impact of ACP-I Plan to improve AD documentation and increase engagement in ACP communication with family and providers among older Latinos with chronic diseases (cancers and non-cancers); and
  2. To evaluate implementation of ACP-I Plan in a community setting and examine further need for adaption.

Participants will be randomized into two groups:

  1. ACP education consisting of
  • a brief social work screening,
  • an educational pamphlet,
  • advance directive forms (in English and Spanish), and
  • community resource materials (i.e., handout); and
  1. ACP education plus counseling consisting of
  • motivational interviewing
  • decisional support, and
  • patient navigation to address barriers We anticipate that ACP-I Plan will be feasibly and acceptable. Participants who receive ACP-I Plan will show 1) greater likelihood of documenting an AD, 2) greater importance of and concern for engaging in ACP communication with family members and providers, and 3) reduced distress at 4-week post intervention.
Being tested
ACP-I Plan
Keywords
Latino, Advance Care Planning, Advance Directive
Medical subject headings
Patient Participation, Death, Chronic Disease, Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACP-I PlanBehavioural

    ACP-I Plan consisting of education, counseling, decisional support, and patient navigation

Study groups in NCT06081660
Study groupRoleWhat they receive
ACP educationActive comparatorACP education consisting of * a brief social work screening, * an educational pamphlet, * advance directive forms (in English and Spanish), and * community resource materials (i.e., handout)
Receives: Behavioral: ACP-I Plan
ACP education plus counselingExperimentalACP education plus counseling consisting of * a brief social work screening, * an educational pamphlet, * advance directive forms (in English and Spanish), and * community resource materials (i.e., handout); * motivational interviewing * decisional support, and * patient navigation to address barriers
Receives: Behavioral: ACP-I Plan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intervention Feasibility

    Feasibility

    We use benchmarks for feasibility.

    1. Number of Participants Recruited, and screening no more than 100 participants,
    2. tracking numbers of participants consented into the study,
    3. percent refused to participate and dropout, amount of time to screen participants and complete a baseline survey once consented into the study,
    4. ACP-I Plan intervention delivered for the first session <2 weeks from their recruitment and randomization date and second session <4 weeks from recruitment,
    5. identify missing data.
    6. Track the number of participants who indicate they returned a completed AD to their provider and/or talked with a family member regarding ACP.

    Measured: 12 months

  2. Satisfaction with intervention

    Acceptability of the intervention

    Satisfaction survey questions includes 14 questions using "I" statements and a 5-point Likert scale: Strongly Disagree to Strongly Agree). Improved scores at follow up indicate satisfaction of information delivery.

    Reference

    Lyon ME, Garvie PA, Briggs L, He J, McCarter R, D'Angelo LJJJopm. Development, feasibility, and acceptability of the Family/Adolescent-Centered (FACE) Advance Care Planning intervention for adolescents with HIV. 2009;12(4):363-372.

    Measured: 1 month

  3. Retention and Attrition Rates

    Feasibility of recruitment and retention

    Measured: 12 months

Secondary outcomes (3)
  1. Completion Rates

    Self report yes/no completed an advance directive document.

    We use the method that Douglas \& Brown (2002) used ask about completion of advance directives at 2 points, baseline and 1-month follow-up. Questions have yes/no [Y/N], responses.

    Reference Douglas R, Brown HN. Patients' attitudes toward advance directives. Journal of Nursing Scholarship.

    2002;34(1):61-65.

    We also use the Advance Directive Attitude Survey (ADAS) by Nolan has 16 items and asks questions (uses a 4-point Likert scale, Strongly Agree to Strongly Disagree with AD decision making). Sixteen questions are subscales and ask about: (a) opportunity for treatment choices, (b) effect of advance directives on the family, (c) effect of an AD on treatment, and (d) perception of illness.

    Nolan MT, Bruder M. Patients' attitudes toward advance directives and end-of-life treatment decisions. Nursing outlook. 1997;45(5):204-208.

    Measured: 1 month

  2. Communication Readiness Provider

    Barriers to ACP communication and readiness to talk with provider.

    We use a barrier scale developed to identify Barriers to Communication about Advance Care Planning (Nedjat-Haiem, 2022) which has 19 questions and uses a scale from 0 to 4, asking how much of a concern is this for you? Readiness to engage in communication about ACP will be assessed by three yes/no questions that ask about: (1) fear of death and dying, (2) difficulty engaging in EOL care communication, and (3) worry about illness severity.

    We also use a readiness scale (1-10) which asks: how ready are you to engage in ACP communication with your physician.

    Measured: 1 month

  3. Communication Readiness Family

    Self Report yes/no - Readiness to talk with a family member

    We also use one question to ask about about readiness using a scale (1-10) which asks: how ready are you to engage in ACP communication with your family member?

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2023
  2. Study start14 Sep 2022
  3. Primary completion16 Apr 2023
  4. Study completion16 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Factorial
Model description
2 x 2 mixed factorial design, pre-test/posttest variables to examine impact on ACP
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06081660
Sponsor's protocol ID
HS-2020-0175
Status last verified
Oct 2023
First submitted
21 Nov 2022
Last updated
13 Oct 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ACP-I Plan in people with Patient Engagement and End of Life, run by San Diego State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intervention Feasibility (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in